Be vigilant in treating a patient with diabetes and COVID-19-associated mucormycosis
Saved in:
| Main Authors: | Pugazhenthan Thangaraju, Hemasri Velmurugan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2023-08-01
|
| Series: | Journal of Family Medicine and Primary Care |
| Online Access: | https://journals.lww.com/10.4103/jfmpc.jfmpc_97_23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gestational diabetes: Unfolded area still a concern
by: Hemasri Velmurugan, et al.
Published: (2023-08-01) -
Need for vigilance monitoring regarding neurological disorders post-COVID vaccination
by: Pugazhenthan Thangaraju, et al.
Published: (2023-08-01) -
Health strategy in South State of India – Towards older people
by: Pugazhenthan Thangaraju, et al.
Published: (2023-08-01) -
COVID-19–associated central nervous system mucormycosis
by: Anjali Mishra, et al.
Published: (2021-01-01) -
Coronavirus disease (COVID-19)-associated mucormycosis (CAM): The unholy triad of COVID-19, diabetes mellitus, and corticosteroid therapy
by: Deepak Juyal, et al.
Published: (2023-11-01)